These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 38224696)
1. Position Paper on Lipid Therapy in Patients with Diabetes Mellitus. Parhofer KG; Birkenfeld AL; Krone W; Lehrke M; Marx N; Merkel M; Schütt KS; Zirlik A; Müller-Wieland D Exp Clin Endocrinol Diabetes; 2024 Feb; 132(2):57-62. PubMed ID: 38224696 [No Abstract] [Full Text] [Related]
2. Position Paper on Lipid Therapy in Patients with Diabetes Mellitus. Parhofer KG; Birkenfeld AL; Krone W; Lehrke M; Marx N; Merkel M; Schütt KS; Zirlik A; Müller-Wieland D Exp Clin Endocrinol Diabetes; 2022 Sep; 130(S 01):S117-S122. PubMed ID: 35359011 [No Abstract] [Full Text] [Related]
3. Position Paper on Lipid Therapy in Patients with Diabetes Mellitus. Parhofer KG; Birkenfeld AL; Krone W; Lehrke M; Marx N; Merkel M; Schütt KS; Zirlik A; Müller-Wieland D Exp Clin Endocrinol Diabetes; 2019 Dec; 127(S 01):S97-S101. PubMed ID: 31860929 [No Abstract] [Full Text] [Related]
4. Management of Lipids in Patients with Diabetes. Mbue ND; Mbue JE; Anderson JA Nurs Clin North Am; 2017 Dec; 52(4):605-619. PubMed ID: 29080581 [TBL] [Abstract][Full Text] [Related]
5. Atherosclerotic disease in non-insulin-dependent diabetes mellitus: role of abnormal lipids and the place for lipid-altering therapies. Orloff DG; Blazing MA; O'Connor CM Am Heart J; 1999 Nov; 138(5 Pt 1):S406-12. PubMed ID: 10539805 [No Abstract] [Full Text] [Related]
6. Dyslipidaemia pattern and prevalence among type 2 diabetes mellitus patients on lipid-lowering therapy at a tertiary hospital in central South Africa. Pitso L; Mofokeng TRP; Nel R BMC Endocr Disord; 2021 Aug; 21(1):159. PubMed ID: 34365977 [TBL] [Abstract][Full Text] [Related]
8. [Reclid effects on carbohydrate, lipid metabolism, lipid peroxidation and hemodynamics in patients with diabetes mellitus type 2]. Shustov SB; Romashevskiĭ BV; Khalimov IuSh; Stepanova OIu; Lysenko AG Klin Med (Mosk); 2000; 78(11):45-8. PubMed ID: 11232532 [TBL] [Abstract][Full Text] [Related]
9. The use of lipid-lowering therapy and effects of antihyperglycaemic therapy on lipids in subjects with type 2 diabetes with or without cardiovascular disease: a pooled analysis of data from eleven randomized trials with insulin glargine 100 U/mL. Hanefeld M; Traylor L; Gao L; Landgraf W Cardiovasc Diabetol; 2017 May; 16(1):66. PubMed ID: 28526014 [TBL] [Abstract][Full Text] [Related]
10. The impact of serum lipids on risk for microangiopathy in patients with type 2 diabetes mellitus. Toth PP; Simko RJ; Palli SR; Koselleck D; Quimbo RA; Cziraky MJ Cardiovasc Diabetol; 2012 Sep; 11():109. PubMed ID: 22978715 [TBL] [Abstract][Full Text] [Related]
11. [The effect of metformin on lipid parameters and on cardiovascular risk in patients with type 2 diabetes without statin therapy]. Kender Z; Groener JB; Reismann P; Kopf S Orv Hetil; 2019 Aug; 160(34):1346-1352. PubMed ID: 31423831 [TBL] [Abstract][Full Text] [Related]
12. Cardiovascular implications of antihyperglycemic therapies for type 2 diabetes. Ovalle F Clin Ther; 2011 Apr; 33(4):393-407. PubMed ID: 21635987 [TBL] [Abstract][Full Text] [Related]
13. Ability of traditional lipid ratios and apolipoprotein ratios to predict cardiovascular risk in people with type 2 diabetes. Taskinen MR; Barter PJ; Ehnholm C; Sullivan DR; Mann K; Simes J; Best JD; Hamwood S; Keech AC; Diabetologia; 2010 Sep; 53(9):1846-55. PubMed ID: 20526762 [TBL] [Abstract][Full Text] [Related]
14. Effects of glycemic control upon serum lipids and lipid transfers to HDL in patients with type 2 diabetes mellitus: novel findings in unesterified cholesterol status. Laverdy OG; Hueb WA; Sprandel MC; Kalil-Filho R; Maranhão RC Exp Clin Endocrinol Diabetes; 2015 Apr; 123(4):232-9. PubMed ID: 25658661 [TBL] [Abstract][Full Text] [Related]
15. Global risk management in type 2 diabetes: blood glucose, blood pressure, and lipids--update on the background of the current guidelines. Clemens A; Siegel E; Gallwitz B Exp Clin Endocrinol Diabetes; 2004 Oct; 112(9):493-503. PubMed ID: 15505756 [TBL] [Abstract][Full Text] [Related]
16. [Determining the current position regarding the value of pioglitazone for the therapy of diabetes]. Eckert S; Erdmann E; Lundershausen R; Forst T; Scherbaum WA; Schnell O; Standl E; Schumm-Draeger PM; Tschöpe D; Walter H; Weber M Dtsch Med Wochenschr; 2007 Dec; 132(49):2650-3. PubMed ID: 18050033 [No Abstract] [Full Text] [Related]
17. Combination lipid therapy in type 2 diabetes mellitus. Vergès B Expert Opin Pharmacother; 2011 Jun; 12(9):1393-403. PubMed ID: 21323502 [TBL] [Abstract][Full Text] [Related]
18. Lipids and diabetes mellitus: a review of therapeutic options. Goguen JM; Leiter LA Curr Med Res Opin; 2002; 18 Suppl 1():s58-74. PubMed ID: 12365820 [TBL] [Abstract][Full Text] [Related]
19. The effects of oral anti-hyperglycaemic medications on serum lipid profiles in patients with type 2 diabetes. Buse JB; Tan MH; Prince MJ; Erickson PP Diabetes Obes Metab; 2004 Mar; 6(2):133-56. PubMed ID: 14746579 [TBL] [Abstract][Full Text] [Related]